IRIS
IRIS Home | Tumor Site Search Results
Searches using filters for organ/system affected are limited to effects (or tumor sites) used to derive the
RfD, RfC, oral slope factor, or inhalation unit risk.
Other effects associated with chemicals in the IRIS database that were not used as the basis for a toxicity value are not searchable with
organ/system filters. IRIS Advanced Search searches only final IRIS assessments; to look for information on draft assessments, see
Quick Check: Assessments in Development.
Search Filtered by: Tumor Site = "Hepatic"
Number of records: 88
| Chemical Name | CASRN | Exposure Route | WOE Characterization | Tumor Type | Toxicity Value |
|---|---|---|---|---|---|
| Aldrin | 309-00-2 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver carcinoma | 4.9 x 10 -4 per µg/L |
| Aldrin | 309-00-2 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver carcinoma | 4.9 x 10 -3 per µg/m3 |
| Aramite | 140-57-8 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Neoplastic liver nodules and carcinomas | 7.1 x 10 -6 per µg/m3 |
| Aramite | 140-57-8 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Neoplastic liver nodules and carcinomas | 7.1 x 10 -7 per µg/L |
| Biphenyl | 92-52-4 | Oral |
Suggestive evidence of carcinogenic potential (2005 guidelines) |
Liver adenomas or carcinomas | 2.3 x 10 -7 per µg/L |
| Bis(chloroethyl)ether (BCEE) | 111-44-4 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatomas | 3.3 x 10 -4 per µg/m3 |
| Bis(chloroethyl)ether (BCEE) | 111-44-4 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatomas | 3.3 x 10 -5 per µg/L |
| Carbon tetrachloride | 56-23-5 | Oral |
Likely to be carcinogenic to humans (2005 guidelines) |
Hepatocellular adenoma or carcinoma | 2 x 10 -6 per µg/L |
| Chlordane (Technical) | 12789-03-6 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Hepatocellular carcinoma | 1 x 10 -5 per µg/L |
| Chlordane (Technical) | 12789-03-6 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Hepatocellular carcinoma | 1 x 10 -4 per µg/m3 |
| Chlordecone (Kepone) | 143-50-0 | Oral |
Likely to be carcinogenic to humans (2005 guidelines) |
liver hepatocellular carcinoma | 3 x 10 -4 per µg/L |
| Chloroform | 67-66-3 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) Likely to be carcinogenic to humans (1999 guidelines) Not likely to be carcinogenic to humans (1999 guidelines) |
Hepatocellular carcinoma | 2.3 x 10 -5 per µg/m3 |
| Chloroprene | 126-99-8 | Inhalation |
Likely to be carcinogenic to humans (2005 guidelines) |
alveolar/ bronchiolar adenoma or carcinoma hemangioma/ hemangiosarcoma (all organs) mammary gland adenocarcinoma, carcinoma, or adenoacanthoma forestomach squamous cell papilloma or carcinoma hepatocellular adenoma or carcinoma Harderian gland adenoma or carcinoma skin sarcoma and Zymbal's gland carcinoma | 3 x 10 -4 per µg/m3 |
| 2,2',3,3',4,4',5,5',6,6'-Decabromodiphenyl ether (BDE-209) | 1163-19-5 | Oral |
Suggestive evidence of carcinogenic potential (2005 guidelines) |
Liver neoplastic nodules or carcinoma (combined) | 2 x 10 -8 per µg/L |
| Di (2-ethylhexyl)phthalate (DEHP) | 117-81-7 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinoma and adenoma | 4 x 10 -7 per µg/L |
| Di (2-ethylhexyl)phthalate (DEHP) | 117-81-7 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinoma and adenoma | 4 x 10 -7 per µg/L |
| Di(2-ethylhexyl)adipate | 103-23-1 | Oral |
C (Possible human carcinogen) (1986 guidelines) |
Combined hepatocellular adenomas and carcinomas | 3.4 x 10 -8 per µg/L |
| Dibromochloromethane | 124-48-1 | Oral |
C (Possible human carcinogen) (1986 guidelines) |
Hepatocellular adenoma or carcinoma | 2.4 x 10 -6 per µg/L |
| Dichloroacetic acid | 79-43-6 | Oral |
Likely to be carcinogenic to humans (1999 guidelines) |
Hepatoadenoma and Hepatocarcinoma | 1.4 x 10 -6 per µg/L |
| p,p'-Dichlorodiphenyl dichloroethane (DDD) | 72-54-8 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver tumors | 6.9 x 10 -6 per µg/L |
| p,p'-Dichlorodiphenyldichloroethylene (DDE) | 72-55-9 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinomas, hepatomas | 9.7 x 10 -6 per µg/L |
| p,p'-Dichlorodiphenyltrichloroethane (DDT) | 50-29-3 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver tumors, benign and malignant | 9.7 x 10 -6 per µg/L |
| p,p'-Dichlorodiphenyltrichloroethane (DDT) | 50-29-3 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver tumors, benign and malignant | 9.7 x 10 -5 per µg/m3 |
| Dichloromethane | 75-09-2 | Oral |
Likely to be carcinogenic to humans (2005 guidelines) |
Hepatocellular carcinomas or adenomas | |
| Dichloromethane | 75-09-2 | Inhalation |
Likely to be carcinogenic to humans (2005 guidelines) |
Hepatocellular carcinomas or adenomas, bronchoalveolar carcinomas or adenomas | 1 x 10 -8 per µg/m3 |
| 1,3-Dichloropropene | 542-75-6 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Hepatocellular adenoma/carcinoma | 1 x 10 -6 per µg/L |
| 1,3-Dichloropropene | 542-75-6 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Hepatocellular adenoma/carcinoma | 2 x 10 -6 per µg/L |
| Dieldrin | 60-57-1 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver carcinoma | 4.6 x 10 -3 per µg/m3 |
| Dieldrin | 60-57-1 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver carcinoma | 4.6 x 10 -4 per µg/L |
| 2,4-/2,6-Dinitrotoluene mixture | Various | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver: hepatocellular carcinomas, neoplastic nodules; mammary gland: adenomas, fibroadenomas, fibromas, adenocarcinomas/ carcinomas | 1.9 x 10 -5 per µg/L |
| 1,4-Dioxane | 123-91-1 | Oral |
Likely to be carcinogenic to humans (2005 guidelines) |
Hepatocellular adenoma and carcinoma | 2.9 x 10 -6 per µg/L |
| 1,4-Dioxane | 123-91-1 | Inhalation |
Likely to be carcinogenic to humans (2005 guidelines) |
Multiple (nasal, liver, kidney, peritoneal, mammary gland, and Zymbal gland) | 5 x 10 -6 per µg/m3 |
| 1,2-Diphenylhydrazine | 122-66-7 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinomas and neoplastic liver nodules | 2.2 x 10 -5 per µg/L |
| 1,2-Diphenylhydrazine | 122-66-7 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinomas and neoplastic liver nodules | 2.2 x 10 -4 per µg/m3 |
| Ethyl Tertiary Butyl Ether (ETBE) | 637-92-3 | Inhalation |
Suggestive evidence of carcinogenic potential (2005 guidelines) |
Hepatocellular adenomas and carcinomas | 8 x 10 -5 per mg/m3 |
| Furmecyclox | 60568-05-0 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Combined liver nodules and carcinomas | 8.6 x 10 -7 per µg/L |
| Heptachlor | 76-44-8 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinomas | 1.3 x 10 -4 per µg/L |
| Heptachlor | 76-44-8 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinomas | 1.3 x 10 -3 per µg/m3 |
| Heptachlor epoxide | 1024-57-3 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinomas | 2.6 x 10 -4 per µg/L |
| Heptachlor epoxide | 1024-57-3 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinomas | 2.6 x 10 -3 per µg/m3 |
| Hexachlorobenzene | 118-74-1 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinoma | 4.6 x 10 -5 per µg/L |
| Hexachlorobenzene | 118-74-1 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinoma | 4.6 x 10 -4 per µg/m3 |
| alpha-Hexachlorocyclohexane (alpha-HCH) | 319-84-6 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatic nodules and hepatocellular carcinomas | 1.8 x 10 -4 per µg/L |
| alpha-Hexachlorocyclohexane (alpha-HCH) | 319-84-6 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatic nodules and hepatocellular carcinomas | 1.8 x 10 -3 per µg/m3 |
| beta-Hexachlorocyclohexane (beta-HCH) | 319-85-7 | Inhalation |
C (Possible human carcinogen) (1986 guidelines) |
Hepatic nodules and hepatocellular carcinomas | 5.3 x 10 -4 per µg/m3 |
| beta-Hexachlorocyclohexane (beta-HCH) | 319-85-7 | Oral |
C (Possible human carcinogen) (1986 guidelines) |
Hepatic nodules and hepatocellular carcinomas | 5.3 x 10 -5 per µg/L |
| technical Hexachlorocyclohexane (t-HCH) | 608-73-1 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver nodules and hepatocellular carcinomas | 5.1 x 10 -5 per µg/L |
| technical Hexachlorocyclohexane (t-HCH) | 608-73-1 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver nodules and hepatocellular carcinomas | 5.1 x 10 -4 per µg/m3 |
| Hexachlorodibenzo-p-dioxin (HxCDD), mixture of 1,2,3,6,7,8-HxCDD and 1,2,3,7,8,9-HxCDD | 57653-85-7 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver tumors (adenomas and carcinomas; neoplastic nodules and hepatocellular carcinomas) | 1.3 per µg/m3 |
| Hexachlorodibenzo-p-dioxin (HxCDD), mixture of 1,2,3,6,7,8-HxCDD and 1,2,3,7,8,9-HxCDD | 57653-85-7 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver tumors (adenomas and carcinomas; neoplastic nodules and hepatocellular carcinomas) | 1.8 x 10 -1 per µg/L |
| Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) | 121-82-4 | Oral |
Suggestive evidence of carcinogenic potential (2005 guidelines) |
Liver (hepatocellular adenomas or carcinomas) and lung (alveolar/bronchiolar adenomas or carcinomas) | |
| Hydrazine/Hydrazine sulfate | 302-01-2 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatoma | 8.5 x 10 -5 per µg/L |
| Nitrobenzene | 98-95-3 | Inhalation |
Likely to be carcinogenic to humans (2005 guidelines) |
Liver hepatocellular adenomas or carcinomas, kidney tubular adenomas or carcinomas, thyroid follicular cell adenomas or carcinomas | 4 x 10 -5 per µg/m3 |
| N-Nitroso-N-methylethylamine | 10595-95-6 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinomas | 6.3 x 10 -4 per µg/L |
| N-Nitrosodi-N-propylamine | 621-64-7 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinomas | 2.0 x 10 -4 per µg/L |
| N-Nitrosodiethanolamine | 1116-54-7 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinoma, cholangiocellular carcinoma and adenoma and neoplastic nodules | 8.0 x 10 -5 per µg/L |
| N-Nitrosodiethylamine | 55-18-5 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver tumors | 4.3 x 10 -2 per µg/m3 |
| N-Nitrosodiethylamine | 55-18-5 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver tumors | 4.3 x 10 -3 per µg/L |
| N-Nitrosodimethylamine | 62-75-9 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver tumors | 1.4 x 10 -3 per µg/L |
| N-Nitrosodimethylamine | 62-75-9 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver tumors | 1.4 x 10 -2 per µg/m3 |
| N-Nitrosopyrrolidine | 930-55-2 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinoma and adenoma | 6.1 x 10 -4 per µg/m3 |
| N-Nitrosopyrrolidine | 930-55-2 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinoma and adenoma | 6.1 x 10 -5 per µg/L |
| Pentachlorophenol | 87-86-5 | Oral |
Likely to be carcinogenic to humans (2005 guidelines) |
Hepatocellular adenomas or carcinomas and adrenal benign or malignant pheochromocytomas | 1.1 x 10 -5 per µg/L |
| Polychlorinated Biphenyls (PCBs) | 1336-36-3 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver hepatocellular adenomas, carcinomas, cholangiomas, or cholangiocarcinomas | |
| Polychlorinated Biphenyls (PCBs) | 1336-36-3 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Liver hepatocellular adenomas, carcinomas, cholangiomas, or cholangiocarcinomas |
1 x 10 -4 per µg/m3 Applies to inhalation of evaporated congeners |
| Prochloraz | 67747-09-5 | Oral |
C (Possible human carcinogen) (1986 guidelines) |
Liver adenoma/ carcinoma combined | 4.3 x 10 -6 per µg/L |
| Quinoline | 91-22-5 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Hepatic hemangioendotheliomas or hemangiosarcomas | 9 x 10 -5 per µg/L |
| 1,1,2,2-Tetrachloroethane | 79-34-5 | Oral |
Likely to be carcinogenic to humans (2005 guidelines) |
hepatocellular carcinomas | 6 x 10 -6 per µg/L |
| 1,1,1,2-Tetrachloroethane | 630-20-6 | Inhalation |
C (Possible human carcinogen) (1986 guidelines) |
Hepatocellular adenoma or carcinoma | 7.4 x 10 -6 per µg/m3 |
| 1,1,1,2-Tetrachloroethane | 630-20-6 | Oral |
C (Possible human carcinogen) (1986 guidelines) |
Hepatocellular adenoma or carcinoma | 7.4 x 10 -7 per µg/L |
| Tetrachloroethylene (Perchloroethylene) | 127-18-4 | Inhalation |
Likely to be carcinogenic to humans (2005 guidelines) |
Hepatocellular adenomas or carcinomas | 2.6 x 10 -7 per µg/m3 |
| Tetrachloroethylene (Perchloroethylene) | 127-18-4 | Oral |
Likely to be carcinogenic to humans (2005 guidelines) |
Hepatocellular adenomas or carcinomas | 6.1 x 10 -8 per µg/L |
| Toxaphene | 8001-35-2 | Oral |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinomas and neoplastic nodules | 3.2 x 10 -5 per µg/L |
| Toxaphene | 8001-35-2 | Inhalation |
B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines) |
Hepatocellular carcinomas and neoplastic nodules | 3.2 x 10 -4 per µg/m3 |
| Trichloroacetic acid | 76-03-9 | Oral |
Suggestive evidence of carcinogenic potential (2005 guidelines) |
Hepatocellular adenomas or carcinomas | 2 x 10 -6 per µg/L |
| 1,1,2-Trichloroethane | 79-00-5 | Inhalation |
C (Possible human carcinogen) (1986 guidelines) |
Hepatocellular carcinoma | 1.6 x 10 -5 per µg/m3 |
| 1,1,2-Trichloroethane | 79-00-5 | Oral |
C (Possible human carcinogen) (1986 guidelines) |
Hepatocellular carcinoma | 1.6 x 10 -6 per µg/L |
| Trichloroethylene | 79-01-6 | Inhalation |
Carcinogenic to humans (2005 guidelines) |
Renal cell carcinoma, non-Hodgkin's lymphoma, and liver tumors | 4.1 x 10 -6 per µg/m3 |
| Trichloroethylene | 79-01-6 | Oral |
Carcinogenic to humans (2005 guidelines) |
Renal cell carcinoma, non-Hodgkin's lymphoma, and liver tumors | |
| 1,2,3-Trichloropropane | 96-18-4 | Oral |
Likely to be carcinogenic to humans (2005 guidelines) |
alimentary system squamous cell neoplasms, liver hepatocellular adenomas or carcinomas, Harderian gland adenomas, uterine/cervix adenomas or carcinomas | |
| Vinyl chloride | 75-01-4 | Inhalation |
A (Human carcinogen) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Liver angiosarcomas, angiomas, hepatomas, and neoplastic nodules |
4.4 x 10 -6 per µg/m3 Continuous lifetime exposure during adulthood |
| Vinyl chloride | 75-01-4 | Inhalation |
A (Human carcinogen) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Liver angiosarcomas, angiomas, hepatomas, and neoplastic nodules |
8.8 x 10 -6 per µg/m3 Continuous lifetime exposure from birth |
| Vinyl chloride | 75-01-4 | Oral |
A (Human carcinogen) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules |
2.1 x 10 -5 per µg/L Continuous lifetime exposure during adulthood |
| Vinyl chloride | 75-01-4 | Inhalation |
A (Human carcinogen) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Liver angiosarcomas, angiomas, hepatomas, and neoplastic nodules |
8.8 x 10 -6 per µg/m3 Continuous lifetime exposure from birth |
| Vinyl chloride | 75-01-4 | Oral |
A (Human carcinogen) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules |
4.2 x 10 -5 per µg/L Continuous lifetime exposure from birth |
| Vinyl chloride | 75-01-4 | Oral |
A (Human carcinogen) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules |
4.2 x 10 -5 per µg/L Continuous lifetime exposure from birth |
| Vinyl chloride | 75-01-4 | Oral |
A (Human carcinogen) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules |
2.1 x 10 -5 per µg/L Continuous lifetime exposure during adulthood |
| Vinyl chloride | 75-01-4 | Inhalation |
A (Human carcinogen) (1986 guidelines) Known/likely human carcinogen (1996 guidelines) |
Liver angiosarcomas, angiomas, hepatomas, and neoplastic nodules |
4.4 x 10 -6 per µg/m3 Continuous lifetime exposure during adulthood |